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Abstract: In our previous study, 8-hydroxydaidzein (8-OHDe) was demonstrated to be a 
potent and unique suicide substrate of mushroom tyrosinase. In this study, the compound 
was evaluated for in vitro cellular tyrosinase and melanogenesis inhibitory activities in 
mouse B16 melanoma cells and for in vivo skin-whitening activity in human volunteers. 
Tyrosinase activity and melanogenesis in the cell culture incubated with 10 µM of 8-OHDe 
were decreased to 20.1% and 51.8% of control, respectively, while no obvious cytotoxicity 
was observed in this concentration. In contrast, a standard tyrosinase inhibitor, kojic acid, 
showed 69.9% and 71.3% of control in cellular tyrosinase and melanogenesis activity, 
respectively, at a concentration as high as 100 µM. Hence, 8-OHDe exhibited more than an 
inhibitory effects on melanin production in B16 cells 10-fold stronger than kojic acid. In 
addition, when a cream containing 4% 8-OHDe was applied to human skin in an in vivo 
study, significant increases in the dL*-values were observed after three weeks. Moreover, 
the increase in the dL*-values after 8-week treatment with 4% 8-OHDe (from -0.57 to 1.94) 
is stronger than those of 2% 8-OHDe treatment (from 0.26 to 0.94) and 2% ascorbic acid-
2-glucoside treatment (from 0.07 to 1.54). From the results of the study, it was concluded 
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that 8-OHDe, the potent suicide substrate of mushroom tyrosinase, has depigmenting 
activities in both mouse melanoma cells and in human volunteers. Thus, the compound has 
significant potential for use in cosmetics as a skin-whitening ingredient.  
Keywords: 8-hydroxydaidzein; suicide substrate; skin whitening; tyrosinase inhibitor 
 
1. Introduction  
 
Mammalian skin color is mainly determined by the content of the pigment melanin, which is 
produced in unique organelles of the neurocrest-derived melanocyte in skin [1]. Melanin plays an 
important role in protecting human skin from the harmful effects of UV radiation from the sun. In 
addition, melanin also determines our phenotypic appearance. Melanin biosynthesis, melanogenesis, is 
initiated with the first step of tyrosine oxidation to dopaquinone catalyzed by tyrosinase. This first step 
is the rate-limiting step in melanin synthesis because the remainder of the reaction sequence can 
proceed spontaneously at a physiological pH value.  
Although melanin has mainly a photoprotective function in human skin, the accumulation of an 
abnormal amount of melanin in different specific parts of the skin resulting in more pigmented patches 
may become an esthetic problem. The phenomenon has encouraged researchers to seek new potent 
tyrosinase inhibitors, which inhibit tyrosinase activity and then reduce melanogenesis, for use as the 
main ingredient in skin-whitening cosmetics. Until now, many tyrosinase inhibitors from natural and 
synthetic sources have been discovered and reviewed [2]. In addition, some of them have been 
intensively studied in human clinical trials, and showed whitening effect in skin of the tested 
volunteers [3–6].  
In contrast to the huge number of reversible tyrosinase inhibitors that has been identified, 
irreversible inhibitors of tyrosinase have rarely been found until now [2]. These irreversible inhibitors 
can form an irreversibly covalent bond with tyrosinase and then inactivate it. Among the irreversible 
inhibitors, suicide substrates belong to a special class. The mechanism of the tyrosinase suicide 
substrate has been extensively studied by Land et al., who demonstrated that suicide inactivation is the 
result of catecholic substrates being processed by the cresolase route [7]. Because the inhibitory 
mechanism of the suicide substrates is completely different from those of reversible inhibitors and 
displays irreversible and partition ratio-dependent inhibition, it has been proposed that the suicide 
substrates have superior performance in skin-whitening activity than those of usual tyrosinase 
inhibitors [2]. However, potent suicide substrates have rarely been discovered, and no suicide substrate 
has been confirmed in depigmenting activity either in cell cultures or in human skin.  
In our continuing search for new tyrosinase inhibitors, some have been found [8–11]. Among them, 
8-hydroxydaidzein (8-OHDe, Figure 1) was recently identified as a potent and unique suicide substrate 
of mushroom tyrosinase with a low partition ratio, a low Michaelis constant, and a high maximal 
inactivation rate constant [8–9]. The compound is a biotransformed metabolite of the soy isoflavone 
daidzein by fungi Aspergillus saitoi or  A. oryzae [12]. In the reviewed literatures,   
8-OHDe has been identified as one of the most potent suicide substrates of mushroom tyrosinase until Int. J. Mol. Sci. 2009, 10                 
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now and has significant potential in application as a skin-whitening agent. Hence, evaluating the 
depigmenting activity of the compound becomes an interesting issue. In this study, 8-OHDe was 
evaluated for in vitro cellular tyrosinase and melanogenesis inhibitory activities in mouse B16 
melanoma cells and for in vivo skin-whitening activity in human volunteers, and the depigmenting 
activities of the compound in both assay systems were confirmed.  
 
Figure 1. Chemical structure of 8-OHDe. 
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2. Results and Discussion  
 
2.1. In Vitro Evaluation of Depigmenting Activity of 8-OHDe in Mouse B16 Melanoma Cells 
 
Before the in vivo skin-whitening assay was conducted, mouse B16 melanoma cells were utilized as 
a cellular assay system to evaluate the depigmenting activity of 8-OHDe in the cell cultures. We used 
kojic acid as positive control in the cellular study due to the potent and known inhibitory effects on 
tyrosinase activity. First, 8-OHDe was applied to these cells at concentrations of 1-10 M for 48 h, and 
cell viability was assessed by the MTT method. As shown in Figure 2, at the concentration of 10 M 
of 8-OHDe, the cell viability retained 93.7%, which had no statistically significant difference 
compared to control. Hence, it was concluded that 8-OHDe did not exert cytotoxicity against B16 cells 
below 10 M. To investigate whether 8-OHDe exerts depigmenting activity on B16 cells, the change 
in the melanin contents of the cells treated with 8-OHDe was evaluated. The result showed that 
melanin contents in the cells with 8-OHDe treatment were significantly reduced in a dose-dependent 
manner (Figure 2), and the 50% inhibitory concentration was 10.54 M by the compound. However, 
kojic acid inhibited melanogenesis of mouse B16 melanoma cells only to 71.7% even at as high a 
concentration as 100 M. In addition, kojic acid also had slight cytotoxicity to the mouse B16 
melanoma cells. Therefore, 8-OHDe, which exhibited more than a 10-fold stronger inhibitory effects 
on melanin production in B16 cells than the standard tyrosinase inhibitor, kojic acid, in view of the 
IC50 values, is regarded as a promising skin-whitening agent. This result encouraged us to explore the 
depigmenting activity of 8-OHDe on human skin in an in vivo study.  
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Figure 2. Effects of 8-OHDe on cell viability, melanin content, and cellular tyrosinase 
activity of mouse B16 melanoma cells. The cells were cultured in 6-well plates and 
incubated with tested agents for 3 d. Cell viability, cellular tyrosinase activity, and melanin 
content were assayed as described in the Experimental section. Bars represent the   
means ± S.D. of three independent experiments. Significant differences were determined 
by Student’s t-test; * p < 0.001; ** p < 0.0001 compared to control. 
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In addition, the effective concentration of 8-OHDe on inhibition of melanogenesis in B16 
melanoma cells was not cytotoxic to the cells. This result suggested that the inhibitory effect of   
8-OHDe on melanin biosynthesis is not due to its cytotoxicity. To investigate the inhibitory 
mechanism by 8-OHDe in reducing melanin contents in B16 melanoma cells, we examined the effect 
of the compound on activity of the key melanogenic enzyme, tyrosinase. We found that the cellular 
tyrosinase activity in B16 cells was strongly inhibited by 8-OHDe, and only 20.1% residual tyrosinase 
activity was retained in the treatment of 10 M (Figure 2). 8-OHDe also decreased the cellular 
tyrosinase activity in a dose-dependent manner, and the 50% inhibitory concentration of the compound 
was 6.17 M. From the results above, it was concluded that 8-OHDe inhibited melanogenesis in B16 
cells due to its effects on reduction of tyrosinase activity. Because 8-OHDe has been proven to be a 
potent suicide substrate of mushroom tyrosinase, we suggested that the compound reduced cellular 
tyrosinase activity in B16 cells due to its suicidal property against tyrosinase. However, some major 
differences exist between the mushroom tyrosinase and the mammalian one. For examples, the 
mushroom tyrosinase is a cytosol enzyme while the mammalian tyrosinase is membrane bonded. In 
addition, mushroom tyrosinase is a tetramer in contrast to the monomer type of the mammalian 
enzyme, which is highly glycosylated during its complex maturation process. Hence, application of the 
result from the study using mushroom tyrosinase to explain the result from the mammalian study takes 
some risk. However, to date, no kinetically inhibitory study of tyrosinase activity has been performed Int. J. Mol. Sci. 2009, 10                 
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with mammalian tyrosinase due to the lack of a purified enzyme. Although some studies used a crude 
extract of melanocytes as the enzyme source to study simple inhibitory effects of tyrosinase inhibitors, 
it is difficult to study the kinetic and mechanistic characterizations of the inhibitors to the specific 
enzyme in the very complex and crude system. In addition, other possible reasons for the reduction of 
the cellular tyrosinase activity by 8-OHDe in B16 cells, such as inhibition of either tyrosinase gene 
expression or tyrosinase protein maturation, cannot be ruled out based on the results of the present 
work. Hence, more detailed experiments for determining the molecular mechanism of 8-OHDe on 
reduction of cellular tyrosinase activity in B16 cells are needed in the future. 
 
2.2. In Vivo Evaluation of Skin-Whitening Activity of 8-OHDe in Human Volunteers  
 
To evaluate the skin-whitening activity of 8-OHDe in advance, we applied the compound on human 
skin in an in vivo study. We used a Chromameter CR-200 photometer to evaluate the skin-whitening 
activity of 8-OHDe in vivo. The skin-whitening index, Luminance (L*)-value of the CIELab space, 
measured by the machine, has been used by dermatologists as an indicator of skin color for a long time 
[13]. The L*-value, ranging from total black (L* = 0) to total white (L* = 100), gives the relative 
brightness of the tested skin. Hence, the increased L*-value of a tested volunteer after drug treatment 
means her skin color is becoming whiter. In addition, kojic acid, which was used as positive control in 
the cellular assay system in the present study, has been reported to exert carcinogenic effects on rats 
and mice [14], and been limited in use on human skin both in European and Taiwan. Hence, in the in 
vivo assay on human volunteers in the present study, we did not use kojic acid as positive control for 
safety concerns. In contrast to kojic acid, ascorbic acid and its derivatives including magnesium   
L-ascorbyl-2-phosphate (VC-PMG) and ascorbic acid-2-glucoside (AA2G) are very safe compounds 
for human use and also the most famous skin-whitening ingredients used in commercial cosmetics  
[15–18]. Among them, AA2G is the newest ascorbic acid derivative and was demonstrated to be 
superior to its precursor ascorbic acid in both stability and drug release [16]. For the reasons, we used 
AA2G as the positive standard in the in vivo skin-whitening assay of the present study. All subjects 
passed the occlusive single patch test for irritation upon exposure to cream containing 4% of 8-OHDe 
and 2% AA2G and thus were included in the study. The initial skin-whitening index L*-value was 
taken from the cheek of each subject before application of the tested substances. The tested substances 
were then applied twice daily on the outer surface of the skin area of each volunteer. Application 
continued for eight weeks, and the skin-whitening index was measured every week. For data 
representations every week, the difference between the mean L*-value of drug-treated volunteers and 
that of placebo-treated volunteers was calculated as the L*-value of the drug treatment.  
Figure 3 shows the representative plots of the time course versus L*-values of the different drug 
treatments. From the result of the positive control (2% AA2G treatment), it could be seen that the  
L*-values increased with the treatment duration, i.e., from 0.07 at starting to 1.54 at week 8. During 
the same period, the L*-values in both the 2% and 4% 8-OHDe treatments also increased with the 
treatment duration, i.e., from 0.26 at beginning to 0.94 at week 8 for 2% 8-OHDe treatment and -0.57 
at beginning to 1.94 at week 8 for 4% 8-OHDe treatment. Among them, the increase in the L*-values 
after 8-week treatment with 4% 8-OHDe (from -0.57 to 1.94) is stronger than those of 2% 8-OHDe 
treatment (from 0.26 to 0.94) and 2% AA2G treatment (from 0.07 to 1.54). When the paired t-test was Int. J. Mol. Sci. 2009, 10                 
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applied to the whitening data at various weeks compared with that at starting, significant differences 
were found after 3-weeks treatment in both 4% 8-OHDe treatment and 2% AA2G treatment. The result 
of the 2% AA2G treatment is comparable with the previous one in which the skin-whitening index  
L*-values of the treated volunteers increased significantly (from -1.14 to 0.36) after 12 weeks of 
treatment with 10% AA2G [18]. However, the L*-values in 2% 8-OHDe treatment during 8 weeks 
contained no significant difference compared with that at beginning. We suggested that the lower 
statistic data was caused by the lower concentration in use, because significant differences were found 
in the L*-values of the 4% 8-OHDe treatment after three weeks. From the results above, it could be 
concluded that the 4% 8-OHDe indeed caused skin whitening in the 15 volunteers after eight weeks of 
treatment and performed superior depigmenting activity than those of the 2% of 8-OHDe and AA2G.  
 
Figure 3. Time course versus L*-values of different drug treatments. The L*-value of a 
drug treatment was calculated from the difference between the mean L*-value of   
drug-treated volunteers and that of placebo-treated volunteers every week. Bars represent 
means ± S.D. of data from the total number of volunteers in the tested concentration. 
Significant differences were determined by Student’s t-test; * p < 0.01 compared to that at 
time zero.  
Time (week)
02468

L
*
-
v
a
l
u
e
-2
-1
0
1
2
3
4
2% AA2G
2% 8-OHDe
4% 8-OHDe
*
*
*
*
*
*
* *
*
* *
 
3. Experimental Section  
 
3.1. 8-OHDe Purification and the Cream Formulation 
 
8-OHDe was purified from soy germ koji fermented with A. oryzae BCRC 32288, which was 
obtained from the Bioresources Collection and Research Center (BCRC, Food Industry Research and 
Development Institute, Hsinchu, Taiwan, ROC). The procedure was as described in our previous work 
[8]. The purified compound was dissolved in dimethyl sulfoxide (DMSO) and added into cell cultures. 
For in vivo skin-whitening assays, the powdered compound was added into an acidic basal cream to Int. J. Mol. Sci. 2009, 10                 
 
 
4263
the tested concentration based on its instability in alkaline solution [19]. The tested cream was 
prepared freshly every month during the in vivo assay. The ingredients of the basal cream was 
composed of glyceryl stearate (3%), liquid paraffin (5%), isopropyl myristate (5%), jojoba oil (2%), 
glycerin (5%), amphisol (0.5%), germaben II (0.7%), and deionized water to 100%.  
 
3.2. Cell Cultures  
 
Mouse B16 melanoma cells (4A5) were obtained from BCRC. The cells were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal bovine serum, at 
37 °C in a humidified, CO2-controlled (5%) incubator. The cells were seeded at an appropriate cell 
density in a 6-well plate. After 24 h of incubation, cells were treated with various concentrations of the 
sample for 48 h in the experiments of cell viability and for 72 h in melanin content and cellular 
tyrosinase activity assays.  
 
3.3. Measurements of Cell Viability 
 
MTT assay was performed to examine the viability of cells. At the end of the drug treatment, the 
cells were incubated with MTT solution for 4 h, and the optical density of each well was read at  
540 nm by a spectrophotometer. 
 
3.4. Determination of Melanin Content 
 
The B16 cells were washed with phosphate buffer saline (PBS) at the end of the drug treatment and 
dissolved in 1 N NaOH containing 10% DMSO for 1 h at 60 °C. The absorbance at 490 nm was 
measured, and melanin content was measured using the authentic standard of synthetic melanin 
(Sigma-Aldrich, St Louis, MO, USA).  
 
3.5. Measurements of Tyrosinase Activity 
 
To measure the tyrosinase activity of the cells, the B16 cells were lysed by incubation at 4 °C for  
30 min in lysis buffer (20 mM sodium phosphate, pH 6.8, 1% Triton X-100, 1 mM PMSF, 1 mM 
EDTA) containing protease inhibitors cocktail (Abcam, Cambridge, UK). The lysates were centrifuged 
at 15,000× g for 10 min to obtain the supernatant as the source of tyrosinase. The reaction mixture 
contained 20 mM phosphate buffer, pH 6.8, 1.25 mM L-dopa (Sigma-Aldrich, and the supernatant. 
After incubation at 37 °C for 30 min, dopachrome formation was monitored by measuring absorbance 
at a wavelength of 475 nm.  
 
3.6. Instruments for in Vivo Measurements 
 
The Chromameter CR-200 (Minolta, Osaka, Japan) is a colorimetric instrument containing a Xenon 
lamp as a light source. In this study, it was used to assess the skin-whitening index of the volunteers. 
The light reflected perpendicular to the skin is collected by photodetectors with colored filters for a Int. J. Mol. Sci. 2009, 10                 
 
 
4264
tristimulus color analysis at 450, 560, and 600 nm, using the L*a*b* system, according to the CIE 
color systems [13]. We considered only the L* parameter. The L*-value gives the relative brightness, 
ranging from total black (L* = 0) to total white (L* = 100). The Chromameter necessitates a 
connection to a computer. After calibration on a white plate, the 8-mm probe is applied to the skin 
simply by the weight of the instrument. After the shutter button is pushed, the results can be 
immediately read on the monitor.  
 
3.7. In Vivo Measurements 
 
The study was approved by the Ethics Committee of the Chia Nan University of Pharmacy and 
Science. Thirty-five female volunteers, aged between 22 and 49 years with normal healthy skin, were 
included in the study. They were divided into four groups with treatments of placebo (five volunteers), 
2% AA2G (five volunteers), 2% 8-OHDe (10 volunteers), and 4% 8-OHDe (15 volunteers). The 
investigation was performed in a double-blind and randomized fashion. All measurements were carried 
out in a climatized room under controlled ambient conditions (room temperature 25 ± 2 °C and relative 
humidity 45 ± 5%). An acclimatization period of at least 20 min was respected before the start of every 
measurement session. As an objective measurement of the color of skin, one type of tristimulus 
reflectance instrument, Chromameter CR-200, was used at each clinical visit. The initial   
skin-whitening index L*-value was taken from the cheek of each subject before application of the 
tested substances. The tested substances were then applied twice daily on the outer surface of the skin 
area of each volunteer. The application continued for 8 weeks, and the skin-whitening index was 
measured at the same skin area every week. During the measurement, the photoreceivers were placed 
perpendicularly on the skin with minimal pressure. Each spot was measured three times, and the 
average of the three measured values was calculated. All the experimental data were expressed as 
means ± S.D. 
 
4. Conclusions  
 
8-OHDe strongly inhibits tyrosinase with a unique suicide-inactivating mode. Until now, no 
tyrosinase suicide substrate has been confirmed to exhibit depigmenting activity either in cell cultures 
or in human skin. In the present study, 8-OHDe was demonstrated to exert potent inhibition in both 
melanogenesis and cellular tyrosinase activities in mouse B16 melanoma cells, where the IC50 values 
of the inhibitions by the compound are 10.54 and 6.17 M, respectively. The depigmenting activity of 
8-OHDe was more than 10-fold higher than a skin-whitening standard, kojic acid, in the cell-culture 
system. In addition, when a cream containing 4% 8-OHDe was applied on human skin, significant 
increases in the L*-values were observed after three weeks. Moreover, the increase in the L*-values 
after 8-week treatment with 4% 8-OHDe (from -0.57 to 1.94) is stronger than those of 2% 8-OHDe 
treatment (from 0.26 to 0.94) and 2% AA2G treatment (from 0.07 to 1.54). From the results of the 
study, it was concluded that 8-OHDe has depigmenting activities in both mouse melanoma cells and in 
human volunteers. Thus, the compound is a potential candidate for use in cosmetics as a   
skin-whitening ingredient. 
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